| P50 | author | Roger S McIntyre | Q88039086 |
| P2093 | author name string | Dietmar Fuchs | |
| | Harald Mangge | |
| | Simon Geisler | |
| | Armin Birner | |
| | Eva Z Reininghaus | |
| | Nina Lackner | |
| | Sieglinde Zelzer | |
| | Bernd Reininghaus | |
| | Hans-Peter Kapfhammer | |
| | Karen Hecht | |
| | Susanne A Bengesser | |
| | Fabian Kattnig | |
| | Renate Unterweger | |
| P2860 | cites work | Kynurenine and its metabolites in Alzheimer's disease patients | Q28288179 |
| | Macrophages, inflammation, and insulin resistance | Q29614351 |
| | The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review | Q30656863 |
| | CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 |
| | Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. | Q33796802 |
| | Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study | Q33941073 |
| | Kynurenines: from the perspective of major psychiatric disorders | Q34260092 |
| | A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder | Q34522317 |
| | Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects | Q34535629 |
| | Neopterin as a marker for immune system activation | Q34633016 |
| | Obesity, diabetes and cognitive deficit: The Framingham Heart Study | Q34651098 |
| | Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. | Q34655648 |
| | The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. | Q34662653 |
| | Midlife overweight and obesity increase late-life dementia risk: a population-based twin study | Q34999328 |
| | New paradigms in neuroendocrinology: relationships between obesity, systemic inflammation and the neuroendocrine system | Q35765871 |
| | Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity | Q36348121 |
| | Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations | Q36628420 |
| | Obesity and the three-year longitudinal course of bipolar disorder | Q36751327 |
| | Chronic immune activation underlies morbid obesity: is IDO a key player? | Q36789479 |
| | Chronic immune stimulation correlates with reduced phenylalanine turnover | Q37264638 |
| | Psychosocial predictors, higher body mass index, and aspects of neurocognitive dysfunction. | Q37342884 |
| | Neurobiological trait abnormalities in bipolar disorder | Q37489488 |
| | Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? | Q37730612 |
| | Bipolar disorder and metabolic syndrome: an international perspective | Q37764504 |
| | Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism | Q37772960 |
| | Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors | Q37799094 |
| | Mood disorders and obesity: understanding inflammation as a pathophysiological nexus | Q37821806 |
| | Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects | Q38203807 |
| | Overweight and cognition | Q38377510 |
| | Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia | Q40229362 |
| | Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes | Q41332326 |
| | Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 |
| | Neurocognitive impairment and psychosocial functioning in bipolar II disorder. | Q43785541 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | Relation between body mass index and cognitive function in healthy middle-aged men and women. | Q44583961 |
| | Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. | Q44874580 |
| | Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study | Q45172222 |
| | Neurocognitive impairment in euthymic patients with bipolar affective disorder | Q45209990 |
| | Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. | Q46036156 |
| | Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 |
| | Mortality of 403 patients with mood disorders 48 to 52 years after their psychiatric hospitalisation | Q46798982 |
| | Obesity-associated cognitive decline: excess weight affects more than the waistline | Q47440188 |
| | Tryptophan breakdown pathway in bipolar mania | Q48290210 |
| | Clinical implications of a staging model for bipolar disorders | Q48530125 |
| | Long-lasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice. | Q50645326 |
| | The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. | Q51008916 |
| | Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder. | Q51894426 |
| | Nitric oxide and neopterin in bipolar affective disorder. | Q51911771 |
| | Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin. | Q51920269 |
| | Interactive effect of obesity indexes on cognition. | Q51934797 |
| | Tryptophan degradation and immune activation in Alzheimer's disease. | Q53235209 |
| | Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. | Q53283282 |
| | Food preservatives sodium sulfite and sorbic acid suppress mitogen-stimulated peripheral blood mononuclear cells. | Q53605663 |
| | Neopterin modulates toxicity mediated by reactive oxygen and chloride species. | Q54658836 |
| | Obesity and lowered cognitive performance in a Canadian First Nations population | Q57155041 |
| | Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone | Q57244071 |
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| | bipolar disorder | Q131755 |
| P304 | page(s) | 432-440 | |
| P577 | publication date | 2013-12-12 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report. | |
| P478 | volume | 16 | |